Article
Reversal of the human and murine multidrug-resistance phenotype with megestrol acetate.
Cancer chemotherapy and pharmacology - 1 Jan 1994
Wang L, Yang C P, Horwitz S B, Trail P A, Casazza A M
Abstract excerpt
MA is an orally active PG derivative with an excellent safety profile that is used primarily for the treatment of carcinomas of the breast and endometrium. We investigated the potential application of MA as an MDR-reversal agent using cell culture and human tumor xenograft models. The reversing activity of MA in vitro was compared with that of PG and VER in two human MDR cell lines, the colon carcinoma...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
